IN PHOTOS: What goes into making a Covid-19 vaccine
Sequencing of the genome, setting the stage for manufacture, conducting clinical trials, signing agreements, as well as holding protests. Forbes India takes a look at the Covid-19 vaccination journey
FebruaryIn February, Ahmedabad-based Zydus Cadila announced that it was initiating an accelerated research programme with multiple teams in India and Europe to develop a vaccine. Researchers at the Vaccine Technology Centre of Zydus Cadila are developing a DNA vaccine &lsquoZyCoV-D&rsquo, which is currently in Phase 2 of clinical trials
Image by Zydus Cadila
2/21
FebruaryAt Australia&rsquos national science agency Commonwealth Scientific and Industrial Research Organisation (CSIRO), George Lovrecz, research team leader of the manufacturing division, works on a fermenter in which vaccine proteins are grown. The CSIRO&rsquos Clayton factory started manufacturing a pilot dose of the vaccine in February, which they called &ldquothe first candidate of
Image by Scott McNaughton/The Age via Getty Images
3/21
FebruaryAdeline Danneels (left), a technician from the French National Centre for Scientific Research (CNIR), and Sandrine Belouzard, virologist, work in a high-level biosafety laboratory at the Pasteur Institute in Lille, France, in February. The research institute sequenced the genome of the coronavirus using blood samples taken from the first few confirmed cases in France
Image by Sylvain Lefevre/Getty Images
4/21
FebruaryPiero Di Lorenzo, president and CEO of IRBM, which is headquartered in Rome, Italy. The research organisation has signed an agreement with The Jenner Institute at Oxford University, UK, for testing the latter&rsquos Covid-19 vaccine
Image by Franco Origlia/Getty Images
5/21
MarchThe headquarters of German biotech firm CureVac in Tübingen, Germany. According to German media outlet Welt am Sonntag, US President Donald Trump sought exclusive access for the United States to a potential coronavirus vaccine under development by CureVac. The issue caused diplomatic ripples with the German government, which wanted the potential vaccine to be available for Europe and
Image by Matthias Hangst/Getty Images
6/21
AprilAbout 220 volunteers from Wuhan, China, the city that is the epicentre of the Covid-19 pandemic, participate in clinical trials of a vaccine candidate developed in the Asian country, which went into Phase 2 of human clinical trials in April
Image by TPG/Getty Images
7/21
AprilRegistered nurse Heather Hoppe was one among the 2,000 frontline staff from the Fiona Stanley Hospital, Sir Charles Gairdner Hospital and the Perth Children&rsquos Hospital in Australia who participated in a research trial to test whether an existing tuberculosis vaccine could help against contracting Covid-19. Half the participants received the existing Bacillus Calmette-Guérin (BCG
Image by Paul Kane/Getty Images
8/21
AprilRobert Langer, co-founder of biotech firm Moderna at his Cape Cod residence in Massachusetts, US. Moderna was one of the first companies to react to the Covid-19 outbreak back in January. Along with the NIH (National Institute of Health), it began working on an mRNA vaccine candidate even before the first coronavirus cases outside of China had been confirmed. This potential Covid-19
Image by Barry Chin/The Boston Globe via Getty Images
9/21
MayIn Germany, people demonstrate in front of the Reichstag building (which houses the German Parliament) against compulsory vaccination and the &ldquofreedom-limiting&rdquo measures of the Federal Government in the context of the spread of Covid-19
Image by Kay Nietfeld/Picture Alliance via Getty Images
10/21
MayA research scientist at Verndari Inc, a biopharmaceutical company in Napa, California in the United States, tests VaxiPatch, a pantented, painless microneedle array derm patch that can be applied to the arm. In April, Verndari, in collaboration with the University of California, Davis, began pre-clinical testing of potential Covid-19 vaccine that can be adminstered through VaxiPatch
Image by Paul Chinn/The San Francisco Chronicle via Getty Images
